The GenScript Life Science Research Grant Program (LSRG Program), now in its second year, continues its mission to support breakthroughs in life science research. This initiative is dedicated to empowering researchers by providing grant funding explicitly earmarked for purchasing GenScript reagents and services. Researchers in diverse life science fields, including but not limited to those listed below, are encouraged to apply and benefit from this unique opportunity to advance their work.
Gene and Cell
Therapy Development
Antibody Drug
Discovery
AI Drug Discovery
Vaccine
Development
Diagnostics
GenScript provides comprehensive “one-stop” solutions for projects in the identified research areas through its advanced technologies and platforms. The Life Science Research Grant Program will leverage GenScript’s existing capabilities to accelerate projects by partnering with investigators globally on their proposed projects.
Over 50 grants are planned and will be awarded based on scientific merit, potential for impact, and strategic alignment with GenScript’s primary areas of scientific interest.
Grants will be awarded at a range of funding levels, dependent on GenScript’s internal committee assessment of the project’s budget needs. The maximum amount to be awarded is set at 100,000 USD for qualifying projects.
Projects are expected to commence promptly after receiving grant funding from GenScript, and research activities should generally take place over 12 months or less.
*Based on EST time